{
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "inverse": true,
    "derivatives": false,
    "swaps": false,
    "complex_factors": [
        "Leverage (-5x)",
        "Inverse exposure",
        "Short-term trading focus (1-day holding period)",
        "High volatility risk"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as 'complex' under MiFID II due to several key factors: (1) **Leverage and Inverse Exposure**: The ETP provides -5x daily inverse exposure to the iShares 20+ Year Treasury Bond ETF, which introduces significant volatility and compounding effects. (2) **Short-Term Trading Focus**: The recommended holding period is 1 day, making it unsuitable for long-term investors and requiring constant monitoring. (3) **High Risk Profile**: The product is classified as risk level 7/7, indicating very high risk. (4) **No Capital Protection**: Investors can lose their entire investment. (5) **Sophisticated Investor Targeting**: The KIID explicitly states the product is intended for sophisticated investors who understand leverage and compounding risks. (6) **Physical Replication Claim**: While the factsheet claims 'physical replication,' the inverse and leveraged nature of the product introduces complexity beyond typical ETFs. (7) **Counterparty Risk**: The collateralized structure involves a trustee enforcing security over assets, adding complexity. (8) **Compounding Effect**: The daily rebalancing can lead to returns diverging significantly from the -5x exposure over time, requiring advanced understanding.",
    "confidence": 95,
    "counter_arguments": "The factsheet claims 'physical replication,' which might suggest lower complexity. However, the inverse and leveraged nature of the product, combined with the high-risk profile and short-term trading focus, override this argument. The product's structure and risks are not easily understandable by retail investors, reinforcing the 'complex' classification.",
    "risk_level_assessment": "The product's risk level (7/7) aligns with its complex classification. The high leverage, inverse exposure, and compounding effects make it unsuitable for retail investors without specialized knowledge."
}